DataMeds AI (MEDS) Non Operating Interest Expenses (2024 - 2026)

DataMeds AI (MEDS) has reported Non Operating Interest Expenses for 3 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Interest Expenses rose 89.37% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 189.07% YoY), and the FY2025 full-year result was $4.6 million, up 450.78% from the prior year.
• Non Operating Interest Expenses grew to $2.1 million in Q1 2026 per MEDS's latest filing, from $875719.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $2.1 million in Q1 2026 and bottomed at $1309.0 in Q2 2024.
• Historically, Non Operating Interest Expenses has averaged $831522.4 across 3 years, with a median of $875719.0 in 2025.
• The widest YoY moves for Non Operating Interest Expenses: up 90353.78% in 2025, down 27.07% in 2025.
• Over 3 years, Non Operating Interest Expenses stood at $689186.0 in 2024, then advanced by 27.07% to $875719.0 in 2025, then jumped by 136.68% to $2.1 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $2.1 million, $875719.0, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.